Raymond James & Associates Airsculpt Technologies, Inc. Transaction History

Raymond James & Associates

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$5.64 - $8.19 $62,322 - $90,499	-11,050 Reduced 25.67%	32,000 $196,000
Q4 2023 Jan 16, 2024	SELL	$4.94 - $7.63 $235,045 - $363,035	-47,580 Reduced 52.5%	43,050 $322,000
Q3 2023 Oct 24, 2023	SELL	$6.5 - $9.53 $22,750 - $33,355	-3,500 Reduced 3.72%	90,630 $619,000
Q2 2023 Jul 25, 2023	SELL	$4.64 - $8.62 $95,444 - $177,313	-20,570 Reduced 17.93%	94,130 $811,000
Q1 2023 Apr 14, 2023	SELL	$3.71 - $7.8 $1,855 - $3,900	-500 Reduced 0.43%	114,700 $578,000
Q4 2022 Feb 08, 2023	BUY	$2.7 - $7.08 $135,540 - $355,416	50,200 Added 77.23%	115,200 $426,000
Q3 2022 Oct 25, 2022	BUY	$5.98 - $11.2 $209,300 - $392,000	35,000 Added 116.67%	65,000 $418,000
Q2 2022 Aug 12, 2022	BUY	$5.93 - $13.99 $85,985 - $202,855	14,500 Added 93.55%	30,000 $178,000
Q1 2022 May 11, 2022	SELL	$11.84 - $16.24 $10,656 - $14,615	-900 Reduced 5.49%	15,500 $212,000
Q4 2021 Feb 08, 2022	BUY	$10.22 - $17.99 $167,608 - $295,036	16,400 New	16,400 $282,000

37.5M

19.7K

Ticker AIRS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 55,640,200
Market Cap $299M
Description
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company prov...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.